Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Turski

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
Arzneimittel-Forschung|May 1, 1990
[The N-methyl-D-aspartate receptor complex. Various sites of regulation and clinical consequences]L Turski
Psychopharmacology|January 1, 1980
Effects of kainic acid on body temperature of rats: role of catecholaminergic and serotonergic systemsL Turski, Z Kleinrok
Metabolic Brain Disease|June 1, 1996
Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonistsC Ikonomidou, L Turski
Trends in Pharmacological Sciences|June 1, 1990
Glutamate: a new target in schizophrenia?H Wachtel, L Turski
Trends in Neurosciences|August 1, 1989
Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's diseaseT Klockgether, L Turski
Annals of Neurology|October 1, 1990
NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted ratsT Klockgether, L Turski
Annals of Neurology|October 1, 1993
Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal gangliaT Klockgether, L Turski
Current Opinion in Neurology|December 1, 1995
Excitotoxicity and neurodegenerative diseasesC Ikonomidou, L Turski
Acta Biochimica Polonica|January 1, 1981
Biochemical consequences of kainic acid injection into the lateral brain ventricle in ratZ Kleinrok, L Turski
Annals of the New York Academy of Sciences|November 25, 1997
Pharmacology of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo-(F)-quinoxalineC Ikonomidou, L Turski
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
Arzneimittel-Forschung|May 1, 1990
[The N-methyl-D-aspartate receptor complex. Various sites of regulation and clinical consequences]L Turski
Psychopharmacology|January 1, 1980
Effects of kainic acid on body temperature of rats: role of catecholaminergic and serotonergic systemsL Turski, Z Kleinrok
Metabolic Brain Disease|June 1, 1996
Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonistsC Ikonomidou, L Turski
Trends in Pharmacological Sciences|June 1, 1990
Glutamate: a new target in schizophrenia?H Wachtel, L Turski
Trends in Neurosciences|August 1, 1989
Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's diseaseT Klockgether, L Turski
Annals of Neurology|October 1, 1990
NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted ratsT Klockgether, L Turski
Annals of Neurology|October 1, 1993
Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal gangliaT Klockgether, L Turski
Current Opinion in Neurology|December 1, 1995
Excitotoxicity and neurodegenerative diseasesC Ikonomidou, L Turski
Acta Biochimica Polonica|January 1, 1981
Biochemical consequences of kainic acid injection into the lateral brain ventricle in ratZ Kleinrok, L Turski
Annals of the New York Academy of Sciences|November 25, 1997
Pharmacology of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo-(F)-quinoxalineC Ikonomidou, L Turski
Pageof 18